[1
]
From the University of Texas MD Anderson Cancer Center, Houston (J.A.B.); Azienda
Ospedaliera Niguarda Cà Granda (A.T.) and Università Vita-Salute San Raffaele and
IRCCS Istituto Scientifico San Raffaele (P.G.), Milan, and the Department of Translational
Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara (G.G.) - all in Italy;
Wilmot Cancer Institute, University of Rochester, Rochester, NY (P.M.B.); Medical
University of Lodz and Copernicus Memorial Hospital, Lodz (T.R.), the Department of
Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice
(S.G.), and the Department of Hematology, University Clinical Center of Medical University
of Gdansk, Gdansk (A.H.) - all in Poland; Tom Baker Cancer Centre, Calgary, AB, Canada
(C.O.); Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine,
Tel Aviv University, Tel Aviv (O.B.), and Hadassah University Hospital, Hebrew University
Medical School, Jerusalem (A.P.) - both in Israel; Leeds Teaching Hospitals, St. James
Institute of Oncology, Leeds (P.H.), Kings College Hospital, London (S.D.), Royal
Bournemouth Hospital, Bournemouth (H.M.), and University of Oxford, Oxford (A.S.)
- all in the United Kingdom; Washington University School of Medicine, St. Louis (N.L.B.);
Jiangsu Province Hospital, Nanjing, China (J.L.); North Shore Hospital, Auckland,
New Zealand (D. Simpson); Stanford University School of Medicine, Stanford (S.C.),
City of Hope National Medical Center, Duarte (T.S.), Pharmacyclics, Sunnyvale (D.
Suri, M.C., F.C., L.S., D.F.J.), and Moores Cancer Center, University of California,
San Diego, San Diego (T.J.K.) - all in California; St. Vincent's Hospital, University
of Melbourne (H.Q.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital
(C.S.T.), Melbourne, VIC, Australia; Institute of Blood Pathology and Transfusion
Medicine, National Academy of Medical Sciences of Ukraine, Lviv, Ukraine (Z.M.); Norton
Cancer Institute, Louisville, KY (D.A.S.);